Hunan Warrant Pharmaceutical Co., Ltd.SSE: 688799

(688799)"Hunan Warrant Pharmaceutical Co., Ltd."Announcement on Voluntary Disclosure of the Subsidiary's Obtaining of the Approval Notice for Its API Marketing Application

· Issued by Hunan Warrant Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 688799 · · 2 pages · Chinese

Summary by 6ix AI

Hunan Warrant Pharmaceutical Co., Ltd. has announced that its subsidiary has received approval for a marketing application for a chemical raw material drug.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/688799hunan-warrant-pharmaceutical-co-ltdannouncement-on-voluntary-disclosure-of-the-subsidiarys-obtaining-of-the-approval-notice-for-its-api-marketing-application

Release

Announcement on Voluntary Disclosure of the Subsidiary's Obtaining of the Approval Notice for Its API Marketing Application

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Hunan Warrant Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Hunan Warrant Pharmaceutical

Later from Hunan Warrant Pharmaceutical

All Hunan Warrant Pharmaceutical news releases